Merck's Keytruda helps lung cancer patients live longer in trial

Go back to Merck's Keytruda helps lung cancer patients live longer in trial
ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 2,121,761       

Bristol-Myers Squibb (NYSE: BMY) Delayed: 59.12 -0.46 (0.77%)
Previous Close $59.58    52 Week High $77.12 
Open $58.88    52 Week Low $49.03 
Day High $59.79    P/E 38.39 
Day Low $58.74    EPS $1.54 
Volume 9,253,469       

Merck & Co. (NYSE: MRK) Delayed: 145.60 +3.22 (2.26%)
Previous Close $142.38    52 Week High $65.46 
Open $141.37    52 Week Low $47.97 
Day High $146.68    P/E 99.05 
Day Low $141.36    EPS $1.47 
Volume 9,288,150